These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16531426)

  • 1. Survival and resistance to imipenem of Pseudomonas aeruginosa on latex gloves.
    Ballesta S; Conejo MC; García I; Rodríguez-Martínez JM; Velasco C; Pascual A
    J Antimicrob Chemother; 2006 May; 57(5):1010-2. PubMed ID: 16531426
    [No Abstract]   [Full Text] [Related]  

  • 2. Resistance to imipenem and zinc in clinical isolates of Pseudomonas aeruginosa.
    Velasco C; Rodríguez JM; Conejo MC; Pascual A
    Int J Antimicrob Agents; 2006 Oct; 28(4):377-8. PubMed ID: 16965905
    [No Abstract]   [Full Text] [Related]  

  • 3. Meropenem and imipenem activity against Pseudomonas aeruginosa isolates from the MYSTIC Program.
    Turner PJ
    Diagn Microbiol Infect Dis; 2006 Nov; 56(3):341-4. PubMed ID: 17049798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An outbreak of imipenem-resistant Pseudomonas aeruginosa in an intensive care unit.
    Majumdar S; Kirby A; Berry N; Williams C; Hassan I; Eddleston J; Burnie JP
    J Hosp Infect; 2004 Oct; 58(2):160-1. PubMed ID: 15474190
    [No Abstract]   [Full Text] [Related]  

  • 5. Increase of imipenem resistance among Pseudomonas aeruginosa isolates from a Polish paediatric hospital (1993-2002).
    Patzer JA; Dzierzanowska D
    Int J Antimicrob Agents; 2007 Feb; 29(2):153-8. PubMed ID: 17157481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective evaluation of imipenem/EDTA combined disc and Etest for detection of metallo-beta-lactamase-producing Pseudomonas aeruginosa.
    Bergès L; Rodriguez-Villalobos H; Deplano A; Struelens MJ
    J Antimicrob Chemother; 2007 Apr; 59(4):812-3. PubMed ID: 17317694
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of outer membrane protein OprD and penicillin-binding proteins in resistance of Pseudomonas aeruginosa to imipenem and meropenem.
    Farra A; Islam S; Strålfors A; Sörberg M; Wretlind B
    Int J Antimicrob Agents; 2008 May; 31(5):427-33. PubMed ID: 18375104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbapenem-induced resistance to beta-lactams in Pseudomonas aeruginosa.
    Giacometti A; Del Prete MS; Cirioni O; Izat MK; Balducci M; Cesarini AM; Scalise G
    J Chemother; 1995 Nov; 7 Suppl 4():76-7. PubMed ID: 8904115
    [No Abstract]   [Full Text] [Related]  

  • 9. [Drug resistance of imipenem-resistant Pseudomonas aeruginosa of lower respiratory tract in pulmonary heart disease of coal worker's pneumoconiosis].
    Yu J; Sun YX; Zhang CH
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2008 Apr; 26(4):236-7. PubMed ID: 18724901
    [No Abstract]   [Full Text] [Related]  

  • 10. A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance.
    Mah TF; Pitts B; Pellock B; Walker GC; Stewart PS; O'Toole GA
    Nature; 2003 Nov; 426(6964):306-10. PubMed ID: 14628055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First occurrence of a Pseudomonas aeruginosa isolate in the United States producing an IMP metallo-beta-lactamase, IMP-18.
    Hanson ND; Hossain A; Buck L; Moland ES; Thomson KS
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2272-3. PubMed ID: 16723605
    [No Abstract]   [Full Text] [Related]  

  • 12. Microbiology: a resistance switch.
    O'Toole GA
    Nature; 2002 Apr; 416(6882):695-6. PubMed ID: 11961541
    [No Abstract]   [Full Text] [Related]  

  • 13. Outbreak of Pseudomonas aeruginosa producing IMP-9-type metallo-beta-lactamase in Guangzhou, China.
    Chao Z; Xiao-Feng W; Dan-Hong S; Jin-Ping Y; Nan-Shan Z
    Int J Antimicrob Agents; 2008 Oct; 32(4):363-5. PubMed ID: 18619819
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prevalence of Acinetobacter baumannii and Pseudomonas aeruginosa isolates resistant to imipenem by production of metallo-beta-lactamase].
    Ait El Kadi M; Aghrouch M; Seffar M; El harti J; Bouklouze A; Cherrah Y; Souly K; Zouhdi M
    Med Mal Infect; 2006 Jul; 36(7):386-9. PubMed ID: 16842953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment with doripenem and tobramycin of ventriculitis due to imipenem- and meropenem-resistant Pseudomonas aeruginosa.
    Gelfand MS; Cleveland KO; Mazumder SA
    J Antimicrob Chemother; 2009 Jun; 63(6):1297-9. PubMed ID: 19369268
    [No Abstract]   [Full Text] [Related]  

  • 16. Rapid development of auricular infection due to imipenem-resistant Pseudomonas aeruginosa following self-administered piercing of high ear.
    Vargas J; Carballo M; Hernández M; Rojas N; Jiménez O; Riera J; Romero L; Rodriguez-Morales AJ; Silva M
    Clin Infect Dis; 2005 Dec; 41(12):1823-4. PubMed ID: 16288414
    [No Abstract]   [Full Text] [Related]  

  • 17. The impact of a cation channel blocker (furosemide) on Pseudomonas aeruginosa PAO1 biofilm architecture.
    Cross JL; Ramadan HH; Thomas JG
    Otolaryngol Head Neck Surg; 2007 Jul; 137(1):21-6. PubMed ID: 17599559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial resistance among clinical isolates of Pseudomonas aeruginosa from patients in a teaching hospital, Riyadh, Saudi Arabia, 2001-2005.
    Babay HA
    Jpn J Infect Dis; 2007 May; 60(2-3):123-5. PubMed ID: 17515646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudomonas aeruginosa in a hydropathic facility: diversity, susceptibility and imipenem resistance mutation.
    Pereira SG; Paixão J; Leitão R; Cardoso O
    Lett Appl Microbiol; 2011 Nov; 53(5):518-24. PubMed ID: 21883318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Needed, new paradigms in antibiotic development.
    Ceri H; Olson ME; Turner RJ
    Expert Opin Pharmacother; 2010 Jun; 11(8):1233-7. PubMed ID: 20384540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.